Related Experiment Video
Updated: Jun 11, 2025

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
NMDARs in Alzheimer's Disease: Between Synaptic and Extrasynaptic Membranes
Sergio Escamilla1,2,3, Javier Sáez-Valero1,2,3, Inmaculada Cuchillo-Ibáñez1,2,3
1Instituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas (UMH-CSIC), 03550 Sant Joan d'Alacant, Spain.
Extrasynaptic N-methyl-D-aspartate receptors (NMDARs) contribute to neurodegeneration in Alzheimer's disease (AD). Understanding their distribution is key to developing new AD therapies.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- N-methyl-D-aspartate receptors (NMDARs) are crucial glutamate receptors involved in synaptic plasticity and neuronal survival.
- Synaptic NMDAR activation promotes plasticity and cell survival, whereas extrasynaptic NMDAR activation can lead to cell death.
- Dysregulation of NMDAR distribution is implicated in neurodegenerative diseases like Alzheimer's disease (AD).
Purpose of the Study:
- To review the concept and distribution of extrasynaptic NMDARs.
- To explore the role of synaptic versus extrasynaptic NMDAR distribution in neuronal dysfunction in AD.
- To examine existing evidence on NMDAR distribution in AD mouse models and human patients.
Main Methods:
- Literature review of existing studies on NMDARs in neuroscience.
- Analysis of research on synaptic and extrasynaptic NMDAR distribution.
- Examination of data from Alzheimer's disease mouse models and human brain samples.
Main Results:
- Extrasynaptic NMDARs are found in both neuronal and non-neuronal cells.
- Altered distribution of synaptic and extrasynaptic NMDARs is a significant factor in Alzheimer's disease pathogenesis.
- Evidence from AD models and patients supports the role of NMDAR dysregulation.
Conclusions:
- The balance between synaptic and extrasynaptic NMDARs is critical for neuronal health.
- Extrasynaptic NMDARs represent a potential therapeutic target for Alzheimer's disease.
- Further research into NMDAR distribution may uncover novel strategies for AD treatment.
More Related Videos
06:44Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
09:49Combined Optogenetic and Freeze-fracture Replica Immunolabeling to Examine Input-specific Arrangement of Glutamate Receptors in the Mouse Amygdala
Published on: April 15, 2016
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Alzheimer's Disease: Treatment